Retaglutide is a novel GLP-1 receptor agonist currently under study for the treatment of metabolic disorders. This drug works by enhancing the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring hormone https://phoebethxv785057.goabroadblog.com/37857079/retaglutide-a-promising-glp-1-receptor-agonist